Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

A topical gel containing rAAT shows a good tolerability profile in patients with atopic dermatitis

Nov. 22, 2004

Scientists at Arachnova patent topical buspirone formulations for skin conditions

Nov. 19, 2004

Canadian approval for new trial of XP-828L for psoriasis

Nov. 16, 2004

BCX-4208 enters clinical development for psoriasis

Nov. 10, 2004

Kahalalide F enters phase II trials for severe psoriasis

Nov. 4, 2004

BPC-157 improves myofibrotic contracture in animal model

Nov. 2, 2004

BAL-4079 enters phase III for severe chronic hand dermatitis

Nov. 2, 2004

New phase I/II study for CYT007-TNFQb for psoriasis

Oct. 28, 2004

Velac NDA accepted for filing

Oct. 27, 2004

Evoclin approved for acne vulgaris

Oct. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...